Certified by Founder Lodge
Glenfarne Group, LLC
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $1,185,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Glenfarne Group, LLC is a New York headquartered, privately held and privately funded proprietary investment platform that seeks to generate superior risk adjusted returns from investments in
| Company | Date | Round | Raised |
|---|---|---|---|
 Snab (YC W22) |
February, 06 ,2023 | Pre-Seed | $1,185,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
RadixArk | $100,000,000 | (May 7, 2026)
XCaliber Health | $6,500,000 | (May 7, 2026)
Astrada | $3,800,000 | (May 7, 2026)
Cytospire Therapeutics Ltd | $82,984,705 | (May 7, 2026)
MOSH | $13,000,000 | (May 7, 2026)
